SI
Sofinnova Investments Portfolio holdings
AUM
$1.47B
This Quarter Return
+38.23%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.11B
AUM Growth
+$1.11B
(+28%)
Cap. Flow
+$148M
Cap. Flow
% of AUM
13.26%
Top 10 Holdings %
Top 10 Hldgs %
68.08%
Holding
74
New
16
Increased
14
Reduced
14
Closed
13
Top Buys
| 1 |
PRNB
Principia Biopharma Inc. Common Stock
PRNB
|
$59.6M |
| 2 |
Y-mAbs Therapeutics
YMAB
|
$55.9M |
| 3 |
AMRN
Amarin Corp
AMRN
|
$30.7M |
| 4 |
Sanofi
SNY
|
$18.4M |
| 5 |
ETTX
Entasis Therapeutics Holdings Inc.
ETTX
|
$12.8M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$14.6M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$10.5M |
| 3 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$8.96M |
| 4 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$8.8M |
| 5 |
BLUE
bluebird bio
BLUE
|
$8.69M |
Sector Composition
| 1 | Healthcare | 86.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Ascendis Pharma
ASND
$11.8B
| $176M | 15.66% | 2,479,514 | – | – |
|
|
OBSV
2
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $85.6M | 7.63% | 4,749,623 | – | – |
|
|
AMRN
3
Amarin Corp
AMRN
$311M
| $84.7M | 7.55% | 5,208,306 +1,886,718 | +57% | +$30.7M |
|
4
Natera
NTRA
$23.1B
| $74.2M | 6.62% | 3,100,560 | – | – |
|
|
PRNB
5
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $59.6M | 5.31% | +2,059,146 | New | +$59.6M |
|
|
6
Y-mAbs Therapeutics
YMAB
$388M
| $55.9M | 4.98% | +2,104,278 | New | +$55.9M |
|
7
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $47.3M | 4.22% | 2,868,221 -25,000 | -0.9% | -$413K |
|
8
Merus
MRUS
$4.98B
| $38.7M | 3.45% | 1,961,039 | – | – |
|
|
BOLD
9
DELISTED
Audentes Therapeutics, Inc
BOLD
| $37M | 3.3% | 933,640 | – | – |
|
|
ONCE
10
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $26.3M | 2.34% | 481,270 | – | – |
|
11
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $23.5M | 2.1% | 922,700 | – | – |
|
12
Aclaris Therapeutics
ACRS
$209M
| $22.4M | 1.99% | 1,539,480 | – | – |
|
|
13
Sanofi
SNY
$121B
| $18.4M | 1.64% | +412,746 | New | +$18.4M |
|
|
AGN
14
DELISTED
Allergan plc
AGN
| $18.3M | 1.63% | 96,021 -15,529 | -14% | -$2.96M |
|
|
NCNA
15
NuCana
NCNA
$6.09M
| $16.6M | 1.48% | 666,666 | – | – |
|
16
Puma Biotechnology
PBYI
$254M
| $15.4M | 1.38% | 336,835 +274,899 | +444% | +$12.6M |
|
|
ETTX
17
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
| $12.8M | 1.14% | +1,180,178 | New | +$12.8M |
|
18
Iterum Therapeutics
ITRM
$30.2M
| $11.4M | 1.02% | 1,726,514 | – | – |
|
19
Rigel Pharmaceuticals
RIGL
$697M
| $10.5M | 0.93% | 3,260,931 +988,204 | +43% | +$3.17M |
|
20
Apellis Pharmaceuticals
APLS
$3.48B
| $9.77M | 0.87% | 549,580 -66,222 | -11% | -$1.18M |
|
21
AstraZeneca
AZN
$248B
| $9.52M | 0.85% | 240,608 -89,192 | -27% | -$3.53M |
|
22
Heron Therapeutics
HRTX
$207M
| $9.36M | 0.83% | 295,589 +37,004 | +14% | +$1.17M |
|
|
ALXN
23
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $9.09M | 0.81% | 65,360 -75,392 | -54% | -$10.5M |
|
|
TSRO
24
DELISTED
TESARO, Inc.
TSRO
| $8.73M | 0.78% | +223,675 | New | +$8.73M |
|
25
Synlogic
SYBX
$17M
| $8.17M | 0.73% | 574,972 | – | – |
|